These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 16645619

  • 1. A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
    Cornetta K, Croop J, Dropcho E, Abonour R, Kieran MW, Kreissman S, Reeves L, Erickson LC, Williams DA.
    Cancer Gene Ther; 2006 Sep; 13(9):886-95. PubMed ID: 16645619
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH, Moscow JA, Huang H, Zujewski JA, O'Shaughnessy J, Sorrentino B, Hines K, Carter C, Schneider E, Cusack G, Noone M, Dunbar C, Steinberg S, Wilson W, Goldspiel B, Read EJ, Leitman SF, McDonagh K, Chow C, Abati A, Chiang Y, Chang YN, Gottesman MM, Pastan I, Nienhuis A.
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [Abstract] [Full Text] [Related]

  • 3. In vivo effects of myeloablative alkylator therapy on survival and differentiation of MGMTP140K-transduced human G-CSF-mobilized peripheral blood cells.
    Cai S, Hartwell JR, Cooper RJ, Juliar BE, Kreklau E, Abonour R, Goebel WS, Pollok KE.
    Mol Ther; 2006 May; 13(5):1016-26. PubMed ID: 16426896
    [Abstract] [Full Text] [Related]

  • 4. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P, Tuchman S, Larochelle A, Metzger ME, Donahue RE, Tisdale JF.
    Stem Cells; 2004 May; 22(6):1062-9. PubMed ID: 15536196
    [Abstract] [Full Text] [Related]

  • 5. Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene.
    Walsh CE, Mann MM, Emmons RV, Wang S, Liu JM.
    J Investig Med; 1995 Aug; 43(4):379-85. PubMed ID: 7552587
    [Abstract] [Full Text] [Related]

  • 6. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
    Kang EM, Hanazano Y, Frare P, Vanin EF, De Witte M, Metzger M, Liu JM, Tisdale JF.
    Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
    [Abstract] [Full Text] [Related]

  • 7. Cytokine mobilization of peripheral blood stem cells in patients with Gaucher disease with a view to gene therapy.
    Nimgaonkar M, Mierski J, Beeler M, Kemp A, Lancia J, Mannion-Henderson J, Mohney T, Bahnson A, Rice E, Ball ED.
    Exp Hematol; 1995 Dec; 23(14):1633-41. PubMed ID: 8542958
    [Abstract] [Full Text] [Related]

  • 8. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE, Kiem HP, Andrews RG.
    Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
    [Abstract] [Full Text] [Related]

  • 9. Retroviral-mediated gene transduction of human alkyltransferase complementary DNA confers nitrosourea resistance to human hematopoietic progenitors.
    Allay JA, Koç ON, Davis BM, Gerson SL.
    Clin Cancer Res; 1996 Aug; 2(8):1353-9. PubMed ID: 9816307
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of gene-marked CD34+ cells after autologous stem cell transplantation for multiple myeloma.
    Alici E, Björkstrand B, Treschow A, Aints A, Smith CI, Gahrton G, Dilber MS.
    Cancer Gene Ther; 2007 Mar; 14(3):227-32. PubMed ID: 17082794
    [Abstract] [Full Text] [Related]

  • 11. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
    Suzuki M, Sugimoto Y, Tsukahara S, Okochi E, Gottesman MM, Tsuruo T.
    Clin Cancer Res; 1997 Jun; 3(6):947-54. PubMed ID: 9815770
    [Abstract] [Full Text] [Related]

  • 12. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
    Ragg S, Xu-Welliver M, Bailey J, D'Souza M, Cooper R, Chandra S, Seshadri R, Pegg AE, Williams DA.
    Cancer Res; 2000 Sep 15; 60(18):5187-95. PubMed ID: 11016647
    [Abstract] [Full Text] [Related]

  • 13. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
    Ford CD, Greenwood J, Anderson J, Snow G, Petersen FB.
    Transfusion; 2006 Feb 15; 46(2):193-8. PubMed ID: 16441594
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
    Takebe N, Xu LC, MacKenzie KL, Bertino JR, Moore MA.
    Cancer Gene Ther; 2002 Mar 15; 9(3):308-20. PubMed ID: 11896448
    [Abstract] [Full Text] [Related]

  • 15. Gene transfer into baboon repopulating cells: A comparison of Flt-3 Ligand and megakaryocyte growth and development factor versus IL-3 during ex vivo transduction.
    Kurre P, Morris J, Horn PA, Harkey MA, Andrews RG, Kiem HP.
    Mol Ther; 2001 Jun 15; 3(6):920-7. PubMed ID: 11407906
    [Abstract] [Full Text] [Related]

  • 16. [In vitro study on transduction of human O(6)-methylguanine-DNA-methyltransferase cDNA into human umbilical cord blood CD34(+) cells].
    Wang J, Xia X, Chen Z, Lu D, Xue J, Ruan C.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Dec 15; 17(6):395-8. PubMed ID: 11110975
    [Abstract] [Full Text] [Related]

  • 17. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I, Steidl U, Fischer JC, Czibere A, Kobbe G, Raschke S, Singh R, Fenk R, Rosskopf M, Pechtel S, von Haeseler A, Wernet P, Tenen DG, Haas R, Kronenwett R.
    Haematologica; 2008 Mar 15; 93(3):347-55. PubMed ID: 18268278
    [Abstract] [Full Text] [Related]

  • 18. Intensified PCV-chemotherapy with optional stem cell support in recurrent malignant oligodendroglioma.
    Zander T, Nettekoven W, Kraus JA, Pels H, Ko YD, Vetter H, Klockgether T, Schlegel U.
    J Neurol; 2002 Aug 15; 249(8):1055-7. PubMed ID: 12195453
    [Abstract] [Full Text] [Related]

  • 19. Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomide.
    Chinnasamy D, Fairbairn LJ, Neuenfeldt J, Treisman JS, Hanson JP, Margison GP, Chinnasamy N.
    Hum Gene Ther; 2004 Aug 15; 15(8):758-69. PubMed ID: 15319033
    [Abstract] [Full Text] [Related]

  • 20. The alpha4beta1 and alpha5beta1 integrins mediate engraftment of granulocyte-colony-stimulating factor-mobilized human hematopoietic progenitor cells.
    Carstanjen D, Gross A, Kosova N, Fichtner I, Salama A.
    Transfusion; 2005 Jul 15; 45(7):1192-200. PubMed ID: 15987366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.